Detection of Methicillin-Resistant Staphylococcus aureus (MRSA) in Specimens from Various Body Sites: Performance Characteristics of the BD GeneOhm MRSA Assay, the Xpert MRSA Assay, and Broth-Enriched Culture in an Area with a Low Prevalence of MRSA Infections

被引:51
作者
Hombach, Michael [1 ]
Pfyffer, Gaby E. [1 ]
Roos, Malgorzata [2 ]
Lucke, Katja [1 ]
机构
[1] Luzerner Kantonsspital Luzern, Ctr Lab Med, Dept Med Microbiol, CH-6000 Luzern 16, Switzerland
[2] Univ Zurich, Biostat Unit, Inst Social & Prevent Med, CH-8001 Zurich, Switzerland
关键词
POLYMERASE-CHAIN-REACTION; TIME PCR PLATFORM; RAPID DETECTION; SWAB SPECIMENS; SOFT-TISSUE; NASAL; SURVEILLANCE; TRANSMISSION; COLONIZATION; SKIN;
D O I
10.1128/JCM.00670-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Universal surveillance upon patient admission is important in reducing the transmission of methicillin-resistant Staphylococcus aureus (MRSA) and associated disease in hospitals. High costs for the health care system in conjunction with MRSA have promoted the development of rapid screening methods to detect MRSA carriers. This study compared two real-time PCR methods, the BD GeneOhm MRSA assay (BDGO) and the Xpert MRSA assay, with broth-enriched culture to define their performance characteristics and rapidity in an area with low MRSA prevalence. In total, 414 swabs from the nose and 389 swabs from the groin from 425 patients were tested. Of those 425 patients, 378 had swabs from both the nose and groin in parallel. Two hundred thirty-one and 194 patients were randomly assigned to the BDGO group and the Xpert MRSA group, respectively. In general, sensitivity, specificity, and negative predictive value (NPV) were high for the BDGO (100%, 98.5%, and 100%, respectively) and the Xpert MRSA (100%, 98.2%, and 100%, respectively), irrespective of whether or not nasal and inguinal specimens were considered alone or combined. In contrast, the positive predictive value (PPV) was lower: before the resolution of discrepant results, the PPVs for nasal and inguinal specimens alone and combined were 87.5%, 86.7%, and 82.4% for the BDGO and 91.7%, 66.7%, and 92.9% for the Xpert MRSA, respectively. After the resolution of discrepant results, PPVs were 93.8%, 93.3% and 94.1% for the BDGO and 91.7%, 88.9% and 92.9% for the Xpert MRSA, respectively. With the BDGO, 4 of 16 carriers were each identified by nasal or inguinal swabs alone, whereas in the Xpert MRSA group, 4 of 13 carriers were exclusively identified by nasal swabs and 2 of 13 were identified by inguinal swabs alone. Both PCR methods showed no significant difference in the number of discrepant results (odds ratio, 0.70 [P = 0.789]), but specimens from wounds and other body sites (axilla, vagina, and throat) produced discrepancies more often than nasal and groin specimens (odds ratios, 4.724 [P = 0.058] and 12.163 [P < 0.001], respectively). The facts that no false-negative PCR results were detected and increased PPVs were found after the resolution of discrepant results point to PCR as the actual gold standard. Since both sensitivity and NPV were exceptionally high for PCR, backup cultures may, therefore, be unnecessary in an area with low prevalence and with a preemptive isolation strategy but may still be useful for PCR-positive specimens because of the lower PPV for both methods and the possibility of susceptibility testing. The median time for analysis, including extraction, hands-on time, and actual PCR was 2 h 20 min for the Xpert MRSA versus 5 h 40 min for the BDGO. Concerning reporting time, including administration and specimen collection, the Xpert MRSA was faster than the BDGO (7 h 50 min versus 17 h).
引用
收藏
页码:3882 / 3887
页数:6
相关论文
共 38 条
[1]  
Altman D., 2000, STAT CONFIDENCE CONF
[2]  
[Anonymous], 2010, CLSI Document M100-S20
[3]   Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus [J].
Bishop, Emma J. ;
Grabsch, Elizabeth A. ;
Ballard, Susan A. ;
Mayall, Barrie ;
Xie, Shirley ;
Martin, Rhea ;
Grayson, M. Lindsay .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2904-2908
[4]   Characterization of the best anatomical sites in screening for methicillin-resistant Staphylococcus aureus colonization [J].
Bitterman, Y. ;
Laor, A. ;
Itzhaki, S. ;
Weber, G. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (04) :391-397
[5]   Controlling methicillin-resistant Staphylococcus aureus:: Quantifying the effects of interventions and rapid diagnostic testing [J].
Bootsma, MCJ ;
Diekmann, O ;
Bonten, MJM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5620-5625
[6]   Epidemiology of methicillin-resistant Staphylococcus aureus [J].
Boucher, Helen W. ;
Corey, G. Ralph .
CLINICAL INFECTIOUS DISEASES, 2008, 46 :S344-S349
[7]   Rapid screening for carriage of methicillin-resistant Staphylococcus aureus by PCR and associated costs [J].
Buehlmann, Manuela ;
Boegli-Stuber, Katja ;
Droz, Sara ;
Muehlemann, Kathrin .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (07) :2151-2154
[8]   Real-time polymerase chain reaction detection of methicillin-resistant Staphylococcus aureus:: impact on nosocomial transmission and costs [J].
Conterno, L. O. ;
Shymanski, J. ;
Ramotar, K. ;
Toye, B. ;
van Walraven, C. ;
Coyle, D. ;
Roth, V. R. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (10) :1134-1141
[9]   Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia:: A meta-analysis [J].
Cosgrove, SE ;
Sakoulas, G ;
Perencevich, EN ;
Schwaber, MJ ;
Karchmer, AW ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :53-59
[10]   Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care [J].
Cunningham, R. ;
Jenks, P. ;
Northwood, J. ;
Wallis, M. ;
Ferguson, S. ;
Hunt, S. .
JOURNAL OF HOSPITAL INFECTION, 2007, 65 (01) :24-28